Device Trial Radar · NCT06580405
A Feasibility Study to Evaluate the Safety of the KNP-1000 Apheresis System in Severe Preeclampsia
Last checked: Nov 19, 2026Latest source record: Aug 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
13
Planned (sponsor's estimate)
Start
Oct 1, 2026
Primary completion
Aug 31, 2027
Study completion Nov 30, 2029
Sponsor
- Lead sponsor
- Kaneka Medical America LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 30, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years, up to 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will primarily evaluate safety of the KNP-1000 apheresis system for pregnant women and their fetuses diagnosed with preeclampsia with severe features between 23- and 32-weeks' gestation (very preterm).
Conditions
- Pre-Eclampsia, Severe
Interventions
KNP-1000 Apheresis SystemDevice
sFlt-1 is removed from the participants' plasma through treatment.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Antepartum maternal and fetal device-related serious adverse eventsTime frame: Until date of delivery
- Postpartum maternal and neonatal device-related serious adverse eventsTime frame: Following delivery until end of follow-up (2 years)
- Maternal, fetal, and neonatal mortalityTime frame: Until end of follow-up (2 years)
4 more outcomes with a free account
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.